Physician profile
Heidi L Schauffele
NPI 1801847306
$1,012.12
in general payments reported to CMS, 2019-2025
10 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.00 · 2020: $30.06 · 2021: $148 · 2022: $32.56 · 2023: $151 · 2024: $189 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710 · Education: $36.12 · Entertainment: $30.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.40 |
| Education | $36.12 |
| Entertainment | $30.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $386.64 | 2020-2025 | Clareon, Total30, Precision 1 |
| Biotissue Holdings INC. | $141.86 | 2024-2025 | |
| Glaukos Corporation | $134.00 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $124.43 | 2025 | Miebo, Xiidra |
| Coopervision INC. | $90.10 | 2020-2023 | Ortho-K Contact Lens |
| Haag-Streit USA, INC. | $36.12 | 2023 | |
| Optos, INC. | $30.64 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $24.47 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $19.86 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Schauffele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.